Log in

Relevant bibliographies by topics / The chronic obstructive pulmonary disease (COPD) / Journal articles

To see the other types of publications on this topic, follow the link: The chronic obstructive pulmonary disease (COPD).

Journal articles on the topic 'The chronic obstructive pulmonary disease (COPD)'

Author: Grafiati

Published: 7 June 2025

Last updated: 2 August 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 journal articles for your research on the topic 'The chronic obstructive pulmonary disease (COPD).'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

TN, Santhosh Kumar. "Osteoporosis in Chronic Obstructive Pulmonary Disease." Journal of Orthopedics & Bone Disorders 8, no. 3 (2024): 1–2. http://dx.doi.org/10.23880/jobd-16000270.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Meridj, Amine, Redouan Belala, Khaled Tlili, and Yacine Djeghri. "Impact of Chronic Obstructive Pulmonary Disease on the Quadriceps." Medical & Clinical Research 10, no. 02 (2025): 01–04. https://doi.org/10.33140/mcr.10.02.03.

Full text

Abstract:

COPD is à major public health challenge and major source of chronic disease and death across the globe. Estimating the prevalence of COPD is complex, as it requires cohorts of patients representative of the population using spirometric measurements. COPD is associated with many comorbidities, including lung cancer, cardiovascular disease, osteoporosis, cachexia and muscle weakness are the most serious and common. COPD is à known complication of peripheral muscle dysfunction, which is associated with exercise intolerance and a darker prognosis. It is interesting to evaluate the peripheral muscl

APA, Harvard, Vancouver, ISO, and other styles

3

Zakaria, Mohamed W., and Heba A. Moussa. "Chronic obstructive pulmonary disease in treated pulmonary tuberculous patients." Egyptian Journal of Bronchology 9, no. 1 (2015): 10–13. http://dx.doi.org/10.4103/1687-8426.153519.

Full text

Abstract:

Abstract Background/Aim To detect the prevalence of chronic obstructive pulmonary disease (COPD) as a sequel of treated pulmonary tuberculosis (PTB). Materials and methods A total of 50 adults, 28 men and 22 women, with a definite diagnosis of PTB and complete antituberculous therapy, with subsequent presentation of exertional dyspnea and/or cough, and expectorations for which no other alternative cause was found, were included in our study. All the patients underwent full history taking, full clinical examination, chest radiography, erythrocyte sedimentation rate, prebronchodilator and postbr

APA, Harvard, Vancouver, ISO, and other styles

4

Muhammad Afandy Fadhilah. "Chronic Obstructive Pulmonary Disease." Jurnal Medika Nusantara 2, no. 2 (2024): 117–25. http://dx.doi.org/10.59680/medika.v2i2.1127.

Full text

Abstract:

Chronic Obstructive Pulmonary Disease (COPD) is a group of progressive lung diseases that commonly affect men over the age of 40, especially heavy smokers and those living in areas with high pollution levels. This disease has a high mortality and morbidity rate and brings significant social and economic burdens. The prevalence of COPD varies across countries, with the highest rate reported in the United States at 37% and in Indonesia at 3.7%, with the highest prevalence in East Nusa Tenggara (10%). According to WHO, in 2020, COPD became the third leading cause of death globally. The methods us

APA, Harvard, Vancouver, ISO, and other styles

5

Mycroft, Katarzyna, and Katarzyna Górska. "Diagnosis and management of COPD in primary care." Medycyna Faktów 14, no. 4 (2021): 350–55. http://dx.doi.org/10.24292/01.mf.0421.3.

Full text

Abstract:

Chronic obstructive pulmonary disease is a significant health problem. However, a large proportion of cases remain undiagnosed. Early diagnosis of chronic obstructive pulmonary disease leads to earlier treatment initiation, and in consequence, to improvement of patients quality of life. The gold standard for chronic obstructive pulmonary disease diagnosis is spirometry and the presence of irreversible obstruction after a bronchodilator. One of the most important interventions in the treatment of chronic obstructive pulmonary disease is anti-smoking education. The main group of drugs used in ch

APA, Harvard, Vancouver, ISO, and other styles

6

Odler, Balázs, and Veronika Müller. "Asthma-COPD overlap szindróma." Orvosi Hetilap 157, no. 33 (2016): 1304–13. http://dx.doi.org/10.1556/650.2016.30520.

Full text

Abstract:

Obstructive lung diseases represent a major health problem worldwide due to their high prevalence associated with elevated socioeconomic costs. Bronchial asthma and chronic obstructive pulmonary disease are chronic obstructive ventilatory disorders with airway inflammation, however they are separate nosological entities based on thedifferent development, diagnostic and therapeutic approaches, and prognostic features. However, these diseases may coexist and can be defined as the coexistence of increased variability of airflow in a patient with incompletely reversible airway obstruction. This ph

APA, Harvard, Vancouver, ISO, and other styles

7

Kida, Kozui. "Chronic obstructive pulmonary disease (COPD)." Nippon Ronen Igakkai Zasshi. Japanese Journal of Geriatrics 40, no. 5 (2003): 455–58. http://dx.doi.org/10.3143/geriatrics.40.455.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

UEKI, JUN, KAKU YOSHIMI, and YOSHINOSUKE FUKUCHI. "Chronic obstructive pulmonary disease; COPD." Juntendo Medical Journal 48, no. 3 (2002): 305–20. http://dx.doi.org/10.14789/pjmj.48.305.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Sukholytka, Mariia. "Hypothyroidism and chronic obstructive pulmonary disease." INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine) 16, no. 8 (2021): 643–47. http://dx.doi.org/10.22141/2224-0721.16.8.2020.222884.

Full text

Abstract:

The risk of chronic obstructive pulmonary disease (COPD), as well as thyroid diseases increases with age. COPD is a common systemic disease associated with chronic inflammation. Many endocrinological disorders, including thyroid gland diseases are related to systemic inflammation. Epidemiological studies suggest that patients with COPD are at higher risk of thyroid disorders. These associations are not well-studied and thyroid gland diseases are not included on the broadly acknowledged list of COPD comorbidities. They may seriously handicap quality of life of COPD patients. Unfortunately, the

APA, Harvard, Vancouver, ISO, and other styles

10

Hayat, Atif Sitwat, Abdul Haque Khan, Ghulam Nabi Pathan, and Mohammad Zubair Mushtaque. "CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)." Professional Medical Journal 23, no. 09 (2016): 1073–78. http://dx.doi.org/10.29309/tpmj/2016.23.09.1701.

Full text

Abstract:

Objectives: Chronic obstructive pulmonary disease (COPD) leads to partialreversible obstruction of airways. The objective of our study is to determine frequency ofelevated C-reactive protein (CRP) level in patients of COPD at Liaquat University HospitalJamshoro/Hyderabad. Study Design: Cross-sectional study. Setting: Medical Unit-I of LiaquatUniversity Hospital Jamshoro/Hyderabad. Period: 1st March 2013 to 31st August 2013. Patientsand Methods: Patients of either sex and ages from 40-80 years old and having COPD for atleast two years duration were included. Patients below 40 years of age, havi

APA, Harvard, Vancouver, ISO, and other styles

11

Ish, Pranav. "An Epidemiological Study on Risk Factors of Chronic Obstructive Pulmonary Disease." Epidemiology International 06, no. 01 (2021): 15–21. http://dx.doi.org/10.24321/2455.7048.202104.

Full text

Abstract:

Introduction: Chronic Obstructive Pulmonary Disease (COPD) is one of the leading causes of morbidity and mortality worldwide and is expected to increase in the coming decades due to increasing air pollution. In a country like India, it is a challenge to control the growing incidence of COPD. For this, it is imperative to understand the various risk factors that lead to the development of COPD including smoking and the ever-worsening environmental air pollution levels. Material and Methods: This prospective case-control study was carried out at the out-patient clinic of pulmonary medicine at ou

APA, Harvard, Vancouver, ISO, and other styles

12

Ish, Pranav. "An Epidemiological Study on Risk Factors of Chronic Obstructive Pulmonary Disease." Epidemiology International 06, no. 01 (2021): 15–21. http://dx.doi.org/10.24321/2455.7048.202104.

Full text

Abstract:

Introduction: Chronic Obstructive Pulmonary Disease (COPD) is one of the leading causes of morbidity and mortality worldwide and is expected to increase in the coming decades due to increasing air pollution. In a country like India, it is a challenge to control the growing incidence of COPD. For this, it is imperative to understand the various risk factors that lead to the development of COPD including smoking and the ever-worsening environmental air pollution levels. Material and Methods: This prospective case-control study was carried out at the out-patient clinic of pulmonary medicine at ou

APA, Harvard, Vancouver, ISO, and other styles

13

Pulatovich, Muminov Kadir. "ANEMIA AND FERROKINETIC PARAMETERS IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE." American Journal of Medical Sciences and Pharmaceutical Research 6, no. 9 (2024): 37–40. http://dx.doi.org/10.37547/tajmspr/volume06issue09-06.

Full text

Abstract:

Background: One of the reasons for the high prevalence and mortality in COPD is considered to be untimely unrecognized and unresolved causes of the development of COPD. At the same time, early detection of COPD and treatment started as early as possible slow down the progression of the disease. Material and methods: 80 patients with COPD were under observation, among whom there were 51 (63.7%) men and 29 (36.3%) women. The average age of the patients was 47±1.5 years. A general blood test was performed according to standard methods. Grade 1 COPD severity was diagnosed in 25 patients, grade II

APA, Harvard, Vancouver, ISO, and other styles

14

Weissler, Jonathan C., and Traci N. Adams. "Eosinophilic Chronic Obstructive Pulmonary Disease." Lung 199, no. 6 (2021): 589–95. http://dx.doi.org/10.1007/s00408-021-00492-0.

Full text

Abstract:

AbstractRecent therapeutic advances in the management of asthma have underscored the importance of eosinophilia and the role of pro-eosinophilic mediators such as IL-5 in asthma. Given that a subset of patients with COPD may display peripheral eosinophilia similar to what is observed in asthma, a number of recent studies have implied that eosinophilic COPD is a distinct entity. This review will seek to contrast the mechanisms of eosinophilia in asthma and COPD, the implications of eosinophilia for disease outcome, and review current data regarding the utility of peripheral blood eosinophilia i

APA, Harvard, Vancouver, ISO, and other styles

15

Alotaibi, Fayez Salem Marzoq, Wafa Jazi Alhamereen, Saosan Abdulrahman Almogisib, et al. "Assessment of Depression and Smoking in Chronic Obstructive Pulmonary Disease Patients." International Journal Of Pharmaceutical And Bio-Medical Science 02, no. 11 (2022): 557–60. http://dx.doi.org/10.47191/ijpbms/v2-i11-15.

Full text

Abstract:

Background: Depression is common in COPD patients, and smokers are more likely to develop it. Methods: The smoking habits of 100 people with COPD were evaluated for the study during either an outpatient visit or a hospital stay. The Hamilton depression rating scale was used to assess depression in the study population (HAM-D). Result: The majority of the COPD patients in the current study were former smokers. The findings indicated that former smokers were more likely to experience depressed symptoms. Conclusion: Depression is a common condition among COPD patients. The findings revealed that

APA, Harvard, Vancouver, ISO, and other styles

16

Nagase, Takahide. "Chronic obstructive pulmonary disease (COPD)." Nippon Ronen Igakkai Zasshi. Japanese Journal of Geriatrics 45, no. 5 (2008): 479–81. http://dx.doi.org/10.3143/geriatrics.45.479.

Full text

APA, Harvard, Vancouver, ISO, and other styles

17

POPE, BARBARA B. "Chronic obstructive pulmonary disease (COPD)." Nursing 34, no. 3 (2004): 56–57. http://dx.doi.org/10.1097/00152193-200403000-00046.

Full text

APA, Harvard, Vancouver, ISO, and other styles

18

Ker, J. A., and J. Ker. "Chronic Obstructive Pulmonary Disease (COPD)." South African Family Practice 45, no. 2 (2003): 3. http://dx.doi.org/10.4102/safp.v45i2.1987.

Full text

APA, Harvard, Vancouver, ISO, and other styles

19

SENIOR, ROBERT M, and NICHOLAS R ANTHONISEN. "Chronic Obstructive Pulmonary Disease (COPD)." American Journal of Respiratory and Critical Care Medicine 157, no. 4 (1998): S139—S147. http://dx.doi.org/10.1164/ajrccm.157.4.nhlbi-12.

Full text

APA, Harvard, Vancouver, ISO, and other styles

20

Feetham, Laura, and Aaron van Dorn. "Chronic obstructive pulmonary disease (COPD)." Lancet Respiratory Medicine 5, no. 1 (2017): 18–19. http://dx.doi.org/10.1016/s2213-2600(16)30442-8.

Full text

APA, Harvard, Vancouver, ISO, and other styles

21

Desole, S., and C. M. Kähler. "Chronic Obstructive Pulmonary Disease (COPD)." memo - Magazine of European Medical Oncology 1, S3 (2008): 3–6. http://dx.doi.org/10.1007/s12254-008-0040-3.

Full text

APA, Harvard, Vancouver, ISO, and other styles

22

Lareau, Suzanne C., Bonnie Fahy, Paula Meek, and Angela Wang. "Chronic Obstructive Pulmonary Disease (COPD)." American Journal of Respiratory and Critical Care Medicine 199, no. 1 (2019): P1—P2. http://dx.doi.org/10.1164/rccm.1991p1.

Full text

APA, Harvard, Vancouver, ISO, and other styles

23

Pahl, A., and I. Szelenyi. "Chronic obstructive pulmonary disease (COPD)." Drugs of the Future 32, no. 9 (2007): 799. http://dx.doi.org/10.1358/dof.2007.032.09.1126938.

Full text

APA, Harvard, Vancouver, ISO, and other styles

24

Weitzenblum, E. "Chronic Obstructive Pulmonary Disease (COPD)." European Respiratory Review 18, no. 112 (2009): 133. https://doi.org/10.1183/16000619/errev.18.112.133.

Full text

APA, Harvard, Vancouver, ISO, and other styles

25

Dr., Ikram Qureshi, Abdul Latif Dr., and Firoz Mansuri Mr. "A Study to Assess the Effectiveness of Selected Nursing Interventions on Knowledge Regarding COPD Functional Capacity of Lungs and Quality of Life Among Patients with Chronic Obstructive Pulmonary Disease COPD in a Selected Hospital at Kota District." Journal of Cardiovascular, Cardiopulmonary Rehabilitation Nursing 1, no. 1 (2023): 28–34. https://doi.org/10.5281/zenodo.7997390.

Full text

Abstract:

<em>COPD is called chronic obstructive pulmonary disease, which is a more serious disease than asthma. COPD is rapidly affecting people all over the world, so it is very important to know about the causes and symptoms of COPD.</em> <em>Often people consider Asthma and COPD to be the same disease because they both have similar symptoms. Both these problems include common symptoms such as cough, phlegm and difficulty in breathing. But both these diseases are very different from each other. COPD is called chronic obstructive pulmonary disease, which is a more serious disease than asthma. COPD Dis

APA, Harvard, Vancouver, ISO, and other styles

26

Cekerevac, Ivan, and Zorica Lazic. "Obesity and chronic obstructive pulmonary disease." Srpski arhiv za celokupno lekarstvo 139, no. 5-6 (2011): 322–27. http://dx.doi.org/10.2298/sarh1106322c.

Full text

Abstract:

Introduction. Nutritional abnormalities have one of the most important systematic effects on chronic obstructive pulmonary disease (COPD). A relationship between COPD and obesity has been observed and recognized. In COPD patients, beside changes in the total body weight, changes in body composition are also possible with the loss of fat-free mass (FFM). Objective. This study was undertaken to evaluate the impact of obesity and the change of body composition on the pulmonary function, dyspnoea level and the quality of life in COPD patients. Methods. Seventy-nine patients in the stable state of

APA, Harvard, Vancouver, ISO, and other styles

27

Tahasildar, Kunal K., and Jagannath S. Shete. "The clinical profile of obstructive lung diseases patients attending tertiary care hospital in Nanded, Maharashtra: an observational study." International Journal of Research in Medical Sciences 6, no. 12 (2018): 3970. http://dx.doi.org/10.18203/2320-6012.ijrms20184892.

Full text

Abstract:

Background: Obstructive lung diseases as asthma and Chronic Obstructive Pulmonary Disease (COPD) have considerable morbidity and mortality globally. Chronic obstructive pulmonary disease (COPD) remains a major public health problem. It is projected to rank fifth in 2020 in burden of disease worldwide, according to the WHO study. Aim and objectives was to evaluate clinical profiles of obstructive lung diseases patients attending tertiary care hospital.Methods: The data was collected from 112 obstructive lung diseases patients presenting to OPD of pulmonary medicine department from January 2009

APA, Harvard, Vancouver, ISO, and other styles

28

Kay, Dana, Roberto Bernardo, and Jean Elwing. "Pulmonary Vascular Disease in Chronic Obstructive Pulmonary Disease." Seminars in Respiratory and Critical Care Medicine 45, no. 05 (2024): 574–81. http://dx.doi.org/10.1055/s-0044-1791824.

Full text

Abstract:

AbstractPulmonary hypertension (PH) is a vascular disease characterized by pulmonary artery remodeling and right heart failure. PH related to COPD is a precapillary form of the disease, with hemodynamic measurements including a mean pulmonary artery pressure of greater than 20 mm Hg, a wedge pressure of less than 15 mm Hg, and a pulmonary vascular resistance of greater than 3 WU (Woods units), categorized under the World Health Organization classification as group 3. The presence of PH in COPD has been known to increase morbidity and mortality. Limited studies have evaluated treatment options

APA, Harvard, Vancouver, ISO, and other styles

29

TLAIS, HADI, and ELDAR KН ANAEV. "POST-TUBERCULOUS OBSTRUCTIVE PULMONARY DISEASE (review of foreign literature)." Bulletin of Contemporary Clinical Medicine 17, no. 1 (2024): 107–18. http://dx.doi.org/10.20969/vskm.2024.17(1).107-118.

Full text

Abstract:

Abstract. Introduction. Post-tuberculous obstructive pulmonary disease has been considered as a chronic disease for the last decade. Despite successful clinical cure of tuberculosis, up to 50% of patients have post-tuberculous obstructive pulmonary disease, defined as the “signs of chronic respiratory distress, with or without symptoms, at least partially attributable to prior pulmonary tuberculosis”. Aim. To consider the epidemiological and pathophysiological relationships between chronic airway obstruction in COPD and tuberculosis and to highlight the diagnostic and therapeutic approaches to

APA, Harvard, Vancouver, ISO, and other styles

30

Sarkar, Malay, Rajeev Bhardwaj, Irappa Madabhavi, and Jasmin Khatana. "Osteoporosis in Chronic Obstructive Pulmonary Disease." Clinical Medicine Insights: Circulatory, Respiratory and Pulmonary Medicine 9 (January 2015): CCRPM.S22803. http://dx.doi.org/10.4137/ccrpm.s22803.

Full text

Abstract:

Chronic obstructive pulmonary disease (COPD) is a lifestyle-related chronic inflammatory pulmonary disease associated with significant morbidity and mortality worldwide. COPD is associated with various comorbidities found in all stages of COPD. The comorbidities have significant impact in terms of morbidity, mortality, and economic burden in COPD. Management of comorbidities should be incorporated into the comprehensive management of COPD as this will also have an effect on the outcome in COPD patients. Various comorbidities reported in COPD include cardiovascular disease, skeletal muscle dysf

APA, Harvard, Vancouver, ISO, and other styles

31

Daga, Mradul Kumar. "Osteoporosis in Chronic Obstructive Pulmonary Disease: More than just a Comorbidity." Journal of Advanced Research in Medicine 07, no. 03 (2020): 7–21. http://dx.doi.org/10.24321/2349.7181.202011.

Full text

Abstract:

Chronic Obstructive Pulmonary Disease (COPD) is one of the leading causes of mortality and loss of Disability-Adjusted Life-Years (DALYs) worldwide. It often is accompanied by the presence of various systemic comorbidities including osteoporosis which may have an impact on the course of the disease. Osteopenia and osteoporosis are the consequences of loss of Bone Mineral Density (BMD) and have been widely known major comorbidities in COPD patients. Female sex, age, and smoking are common pathogenic factors for both COPD and osteoporosis, other factors such as reduced daily physical activity, m

APA, Harvard, Vancouver, ISO, and other styles

32

Gupta, Nidhi, Chitralekha Vora, Pankaj Garg, Kinjal Patel, and Harshad Chovatiya. "Clinical and Echocardiographic Profile of Patients with Chronic Obstructive Pulmonary Disease." Indian Journal of Emergency Medicine 4, no. 2 (2018): 99–103. http://dx.doi.org/10.21088/ijem.2395.311x.4218.5.

Full text

Abstract:

Background: Chronic obstructive pulmonary disease is the fourth leading cause of mortality worldwide. It is defined as a disease formal categorized by airflow limitation that is not fully reversible. Patients with chronic obstructive pulmonary disease (COPD) are at increased risk of cardiovascular disease. Electrocardiography (ECG) carries information about cardiac disease and prognosis in COPD patients. However, Echocardiography provides a rapid, noninvasive, portable, and accurate method to evaluate cardiac functions. Methods: 125 patients of COPD fulfilling the inclusion criteria coming to

APA, Harvard, Vancouver, ISO, and other styles

33

Janković, Jelena, Ivana Buha, Aleksandar Jandrić, and Jasmina Opačić. "Chronic obstructive pulmonary disease and osteoporosis." Galenika Medical Journal 2, no. 7 (2023): 74–77. http://dx.doi.org/10.5937/galmed2307074j.

Full text

Abstract:

Chronic obstructive pulmonary disease (COPD) is a progressive disease characterized by broncho-obstruction, loss of lung elasticity and parenchymal destruction. Today, this disease is the third cause of death in the world. Smoking is the main risk factor for this disease, while other risk factors are vitamin D deficiency, physical inactivity, and the use of systemic corticosteroids. Osteoporosis is a very common comorbidity in patients with COPD and is characterized by lower bone density and changes in the microarchitecture of the bone, which leads to fracture. These two diseases have the same

APA, Harvard, Vancouver, ISO, and other styles

34

Cazzola, Mario, Paola Rogliani, Josuel Ora, Luigino Calzetta, Davide Lauro, and Maria Gabriella Matera. "Hyperglycaemia and Chronic Obstructive Pulmonary Disease." Diagnostics 13, no. 21 (2023): 3362. http://dx.doi.org/10.3390/diagnostics13213362.

Full text

Abstract:

Chronic obstructive pulmonary disease (COPD) may coexist with type 2 diabetes mellitus (T2DM). Patients with COPD have an increased risk of developing T2DM compared with a control but, on the other side, hyperglycaemia and DM have been associated with reduced predicted levels of lung function. The mechanistic relationships between these two diseases are complicated, multifaceted, and little understood, yet they can impact treatment strategy. The potential risks and benefits for patients with T2DM treated with pulmonary drugs and the potential pulmonary risks and benefits for patients with COPD

APA, Harvard, Vancouver, ISO, and other styles

35

Aisanov, Z. R., A. G. Chuchalin, and E. N. Kalmanova. "Chronic obstructive pulmonary disease and cardiovascular comorbidity." Kardiologiia 59, no. 8S (2019): 24–36. http://dx.doi.org/10.18087/cardio.2572.

Full text

Abstract:

In recent years, a greater understanding of the heterogeneity and complexity of chronic obstructive pulmonary disease (COPD) has come from the point of view of an integrated clinical assessment of severity, pathophysiology, and the relationship with other pathologies. A typical COPD patient suffers on average 4 or more concomitant diseases and every day about a third of patients take from 5 to 10 different drugs. The mechanisms of the interaction of COPD and cardiovascular disease (CVD) include the effects of systemic inflammation, hyperinflation (hyperinflation) of the lungs and bronchial obs

APA, Harvard, Vancouver, ISO, and other styles

36

Desai, Himanshu, and Bhavin Dalal. "Management Options in Chronic Obstructive Pulmonary Disease." Clinical Medicine Insights: Therapeutics 4 (January 2012): CMT.S6563. http://dx.doi.org/10.4137/cmt.s6563.

Full text

Abstract:

Chronic obstructive pulmonary disease (COPD) is a leading respiratory disease in the world and third leading cause of death in United States. COPD is not recognized as an isolated respiratory disease anymore; in fact it is one of the dreaded diseases with significant systemic involvement and complications. Treatment of COPD requires team work and efforts among physicians, nurses, respiratory therapists and physical therapists. Treatment of patients with frequent exacerbations is a heavy burden on healthcare network. In the last few years, some improvements in the management of COPD have been m

APA, Harvard, Vancouver, ISO, and other styles

37

González-Herrera, Miguel, and José Ruiz-León. "Vitamin D and Chronic Obstructive Pulmonary Disease." Science Insights 41, no. 5 (2022): 687–90. http://dx.doi.org/10.15354/si.22.re085.

Full text

Abstract:

Chronic obstructive pulmonary disease (COPD) is one of the most prevalent diseases of the respiratory system in the elderly, and it poses a grave threat to the survival and quality of life. Examining the pathogenesis of COPD is extremely important for COPD prevention and treatment. To date, however, there is no medication for chronic obstructive pulmonary disease that can delay the lung function decline over time. According to studies, vitamin D offers new hope for the treatment of COPD. A deficiency in vitamin D can exacerbate the progression of COPD, whereas adequate vitamin D has a therapeu

APA, Harvard, Vancouver, ISO, and other styles

38

Choudhary, Sumer. "Chronic Obstructive Pulmonary Disease: The future." Panacea Journal of Medical Sciences 6, no. 3 (2016): 115–16. https://doi.org/10.18231/2348-7682.2016.0001.

Full text

Abstract:

Chronic obstructive pulmonary disease (COPD) isone of the major causes of morbidity and mortalityacross the world. Almost 90% of COPD deaths areoccurring in low and middle - income countries.(1,2)Chronic Obstructive Pulmonary Disease (COPD) isa common, preventable and treatable disease that ischaracterized by persistent respiratory symptoms andairflow limitation that is due to airway and/or alveolarabnormalities usually caused by significant exposure tonoxious particles or gases.(3) This refined definitionincludes the impact of symptoms and developmentalorigins

APA, Harvard, Vancouver, ISO, and other styles

39

McNicholas, Walter T. "Chronic Obstructive Pulmonary Disease and Obstructive Sleep Apnoea." European Respiratory & Pulmonary Diseases 03, no. 01 (2017): 23. http://dx.doi.org/10.17925/erpd.2017.03.01.23.

Full text

Abstract:

The overlap syndrome (OS) of chronic obstructive pulmonary disease (COPD) and obstructive sleep apnoea (OSA) is common but often missed in clinical practice. Different clinical COPD phenotypes influence the likelihood of co-existing OSA with the predominant emphysema phenotype being protective whereas the predominant chronic bronchitis phenotype promotes the development of OSA. The management of OS differs from COPD alone, particularly the use of nocturnal positive airway pressure (PAP), and patients with OS not treated with PAP have a worse prognosis, which underlines the importance of correc

APA, Harvard, Vancouver, ISO, and other styles

40

Brusasco, Vito, and Fernando Martinez. "Chronic Obstructive Pulmonary Disease." Comprehensive Physiology 4, no. 1 (2014): 1–31. https://doi.org/10.1002/j.2040-4603.2014.tb00539.x.

Full text

Abstract:

AbstractCOPD is characterized by airflow limitation that is not fully reversible. The morphological basis for airflow obstruction results from a varying combination of obstructive changes in peripheral conducting airways and destructive changes in respiratory bronchioles, alveolar ducts, and alveoli. A reduction of vascularity within the alveolar septa has been reported in emphysema. Typical physiological changes reflect these structural abnormalities. Spirometry documents airflow obstruction when the FEV1/FVC ratio is reduced below the lower limit of normality, although in early disease stage

APA, Harvard, Vancouver, ISO, and other styles

41

O’Reilly, Sean. "Chronic Obstructive Pulmonary Disease." American Journal of Lifestyle Medicine 11, no. 4 (2016): 296–302. http://dx.doi.org/10.1177/1559827616656593.

Full text

Abstract:

COPD is a common, preventable, and treatable disease characterized by persistent airflow obstruction associated with enhanced inflammation in the airways and the lung in response to noxious particles or gases. Clinical history and pulmonary function testing are necessary for accurate diagnosis. While exposure to tobacco smoke remains a common cause, other etiologies and underlying genetic predisposition play significant roles. Treatment options are numerous and should be individualized based on symptoms and exacerbation frequency.

APA, Harvard, Vancouver, ISO, and other styles

42

Babanov, S. A. "Epidemiology of chronic obstructive pulmonary disease." Terapevt (General Physician), no. 3 (March 25, 2025): 62–71. https://doi.org/10.33920/med-12-2503-06.

Full text

Abstract:

At the epidemiological stage of the study, 2063 people (903 men and 1160 women) were examined in four age cohorts: 30–39 years, 40–49 years, 50–59 years, 60 years and older in the Kirovsky and Krasnoglinsky districts of Samara. The results of the study showed a fairly high incidence of COPD (COPD) in a large industrial center of the Middle Volga region. In the total cohort, COPD was detected in 14.49 % of the 2063 men and women examined, without separation by gender (at 30–39 years — 10.76 %, at 40–49 years — 10.89 %, at 50–59 years — 15.88 %, at 60 years and older — 21.30 %). COPD was detecte

APA, Harvard, Vancouver, ISO, and other styles

43

Kwok, Wang-Chun, Jin-Ning Clarabel Wong, Aaron Cheung, and Terence Chi-Chun Tam. "Vaccination in Chronic Obstructive Pulmonary Disease." Vaccines 13, no. 3 (2025): 218. https://doi.org/10.3390/vaccines13030218.

Full text

Abstract:

Chronic obstructive pulmonary disease (COPD) is often exacerbated by various viruses and bacteria, leading to acute episodes of worsening respiratory symptoms, which contribute significantly to the morbidity and mortality associated with COPD. Consequently, vaccination against these pathogens is recommended by numerous guidelines to safeguard COPD patients from adverse health outcomes. The Global Initiative for Chronic Obstructive Lung Disease (GOLD) recommendation advocates for vaccination against influenza, Streptococcus pneumoniae, respiratory syncytial virus (RSV), severe acute respiratory

APA, Harvard, Vancouver, ISO, and other styles

44

NUGRAHA, IDA BAGUS ADITYA, and IDA AYU PUTU PADMI DEVIANI. "MANAGEMENT OF PULMONAL HYPERTENSION IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE." Jurnal Kedokteran Raflesia 9, no. 1 (2023): 36–47. http://dx.doi.org/10.33369/juke.v9i1.28838.

Full text

Abstract:

Chronic obstructive pulmonary disease (COPD) is an obstructive pulmonary disease due to inflammatory processes of the respiratory tract and lung parenchyma. In some cases of COPD, changes in the pulmonary vessels are found which are not uncommon, causing impaired gas exchange and causing pulmonary hypertension which is associated with increased morbidity and mortality. Pulmonary hypertension is an increase in the mean pulmonary artery pressure (Pulmonary Arterial Pressure) greater than or equal to 25 mmHg at rest as assessed by a right heart catheterization procedure. Pulmonary hypertension (H

APA, Harvard, Vancouver, ISO, and other styles

45

Viktorova, I. B., V. N. Zimina, and A. V. Kravchenko. "Chronic obstructive pulmonary disease and HIV-infection." HIV Infection and Immunosuppressive Disorders 12, no. 4 (2021): 23–31. http://dx.doi.org/10.22328/2077-9828-2020-12-4-23-31.

Full text

Abstract:

The increasing life expectancy of HIV-infected persons due to antiretroviral therapy (ART) is associated with growing frequency of non-opportunistic respiratory diseases. This review of literature is devoted to chronic obstructive pulmonary disease (COPD), which is known to be the most common chronic noninfectious lung condition in HIV-patients. The prevalence of COPD in the global population with HIV is high and is associated with HIV.The article contains actual data on HIV/COPD comorbidity, presents current information on mechanism of COPD development in HIV-infection, factors contributing t

APA, Harvard, Vancouver, ISO, and other styles

46

Alina, Popa Nicoleta. "Stage 4 COPD, Chronic Pulmonary Heart Disease and COVID 19 Infection." Internal Medicine 18, no. 6 (2021): 67–71. http://dx.doi.org/10.2478/inmed-2021-0192.

Full text

Abstract:

Abstract Chronic obstructive pulmonary disease (COPD) is a chronic disease of the respiratory airways due to partially reversible obstruction of the airflow caused by an abnormal inflammatory response to toxic substances, most often cigarette smoke. COVID-19 is a mild to severe respiratory disease caused by a coronavirus from the genus Betacoronavirus. Chronic cor pulmonale is a severe complication of COPD. Stroke is common in the course of COVID disease,with a major impact on the patient.

APA, Harvard, Vancouver, ISO, and other styles

47

Ferrera, Michael C., Wassim W. Labaki, and MeiLan K. Han. "Advances in Chronic Obstructive Pulmonary Disease." Annual Review of Medicine 72, no. 1 (2021): 119–34. http://dx.doi.org/10.1146/annurev-med-080919-112707.

Full text

Abstract:

Chronic obstructive pulmonary disease (COPD) is a common respiratory disorder with significant morbidity and mortality. Despite its prevalence, COPD is underdiagnosed, and many patients do not receive a diagnosis until the disease is clinically advanced. Recent basic science and clinical research have focused on the early physiologic and pathobiologic changes in COPD with the hopes of improving diagnosis, providing targets for disease-modifying therapy, and identifying patients most likely to benefit from early intervention. Available treatments for COPD have grown substantially in the past 20

APA, Harvard, Vancouver, ISO, and other styles

48

Glova, S. E., and I. V. Razumovsky. "Chronic obstructive pulmonary disease and atrial fibrillation." South Russian Journal of Therapeutic Practice 2, no. 4 (2021): 22–29. http://dx.doi.org/10.21886/2712-8156-2021-2-4-22-29.

Full text

Abstract:

Chronic obstructive pulmonary disease (COPD) has a close relationship with the development of heart failure and atrial fibrillation (AF). In the pathogenesis of AF in patients with COPD, decreased oxygenation, hypercapnia, pulmonary hypertension, diastolic dysfunction, oxidative stress, inflammation, changes in atrial size, and the use of respiratory drugs for the treatment of COPD are important. Understanding the relationship between COPD and AF is of particular importance because the presence of arrhythmias has a significant impact on mortality, especially in exacerbations of COPD. In the pr

APA, Harvard, Vancouver, ISO, and other styles

49

Magd, Galal-Eldin M., Ahmad S. Entesar, Hafez R. Manal, Sobh M. Eman, and Alrayes H. Mona. "Telomere length in chronic obstructive pulmonary disease." Egyptian Journal of Bronchology 9, no. 1 (2015): 20–26. http://dx.doi.org/10.4103/1687-8426.153569.

Full text

Abstract:

Abstract Background Telomere length (TL) is considered a biomarker of cellular aging. Chronic obstructive pulmonary disease (COPD) is found to be associated with premature aging and the senescence hypothesis is now accepted as a molecular pathway for COPD development. Purpose The aim of this study was to measure TL in COPD patients and to study its relation to demographic data, spirometric indices, and arterial blood gases parameters. Participants and methods We measured TL using quantitative PCR in 20 patients with severe to very severe COPD and 11 age-matched and sex-matched nonsmokers. Resu

APA, Harvard, Vancouver, ISO, and other styles

50

Shivam, Limbore* Varad Lad Shubham Pathak Akshay Nikhade Bankar Ganesh. "Management of Chronic Obstructive Pulmonary Diseases." International Journal of Pharmaceutical Sciences 3, no. 4 (2025): 3224–31. https://doi.org/10.5281/zenodo.15286997.

Full text

Abstract:

Chronic obstructive pulmonary disease (COPD) remains a leading cause of death worldwide, yet only one new drug class has been approved in the last decade. However, a recent surge in COPD treatment has been fueled greater understanding of the pathophysiology and natural history of the disease, as well as a growing prevalence and a population that is aging. Currently, there are nearly 25 novel drug targets in development. Furthermore, the indication has undergone some fundamental changes over the last couple of years, including an updated diagnosis paradigm, validation, and approval of patient-r

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!